The FDA-approved dosing schedule involves starting at 2.5 mg subcutaneously once weekly and increasing by 2.5 mg increments every four weeks as tolerated, with available strengths of 2.5, 5, 7.5, 10, 12.5, and 15 mg
One psychiatrist on Sermo takes a measured approach in hopes of getting through to patients
A medical expert can help you weigh the potential benefits against the risks and determine if KLOW is a safe and appropriate choice for you
Although the reasons behind the link are unclear, experts believe its likely a combination of factors
It works similarly to a natural hormone, GLP-1, that is produced by the stomach and controls insulin release, the speed at which the stomach empties, and appetite
doi: 10.3389/fped.2023.1212405 Received 26 April 2023 Accepted 03 July 2023 Published 27 July 2023 Volume 11 - 2023 Edited by Massimo Zeviani, University of Padua, Italy Reviewed by Carlo Fiore Viscomi, University of Padua, Italy Muhammad Ikram Ullah, Jouf University, Saudi Arabia Updates Copyright 2023 Wu, Jiao, Xia, Yan, Liu, Cao and Ma